Galena Biopharma
  • About Us
    • Leadership
    • Career Opportunities
  • Products
    • Abstral®
  • Clinical Development
    • Pipeline
    • Clinical Trials
    • NeuVax™ (nelipepimut-S)
    • FBP (E39)
    • Technology
  • Business Development
  • Investors
    • Stock Information
    • Press Releases
    • Events & Presentations
    • SEC Filings
    • Email Alerts
    • Corporate Governance
    • Analyst Coverage
  • News
  • Resources
Discovery. Delivery. Development. Technology

Galena Biopharma develops innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care.

Click to Learn How NeuVax Works
Click to View the Latest Galena Biopharmaceuticals Comany Presentation
Click to View the Latest Galena Biopharmaceuticals Shareholder Letter
Click to View the Latest Galena Biopharmaceuticals Annual Report

Galena Biopharma in the News

Galena Biopharma Provides Product Pipeline Update at the ASCO 2013 Annual Meeting

Galena Biopharma to Present at the Jefferies 2013 Global Healthcare Conference

Galena Biopharma to Present at the 2013 Marcum MicroCap Conference

Galena Biopharma Poster Presentation at the American Pain Society 32nd Annual Scientific Meeting

More news
Email Print
  • Home
  • Legal
  • LinkedIn
  • Galena Biopharma. All rights reserved.
info@galenabiopharma.com
1-855-855-GALE
310 N. State Street, Suite 208 | Lake Oswego, OR 97034